✦ LIBER ✦

Malignancy in systemic lupus erythematosus: what have we learned?

✍ Scribed by Sasha Bernatsky; Rosalind Ramsey-Goldman; Ann E. Clarke

Book ID: 113490291
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 124 KB
Volume: 23
Category: Article
ISSN: 1521-6942
DOI: 10.1016/j.berh.2008.12.007

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Malignancy in systemic lupus erythematos

Malignancy in systemic lupus erythematosus

✍ Mahmoud Abu-Shakra; Dafna D. Gladman; Murray B. Urowitz 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 465 KB 👁 2 views

Malignancies in systemic lupus erythemat

Malignancies in systemic lupus erythematosus

✍ Emese Kiss; Laszlo Kovacs; Peter Szodoray 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 170 KB

What we have learned in fifty years

✍ Jiro Hirano 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 216 KB

Revisiting the issue of malignancy risk

Revisiting the issue of malignancy risk in systemic lupus erythematosus

✍ Ann E. Clarke; Rosalind Ramsey-Goldman; Sasha Bernatsky 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 225 KB

Treatment of systemic lupus erythematosu

Treatment of systemic lupus erythematosus: which options do we have for therapy regimens?

✍ L. Kater; R. H. W. M. Derksen; R. J. Hené 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 496 KB

The prognosis of systemic lupus erythematosus has improved markedly. This has been due to various factors: improved serological testing leading to better diagnosis, better understanding of secondary complications, and the possibility of treating these. How much has improved treatment of the primary

Polyreactive autoantibodies in systemic

Polyreactive autoantibodies in systemic lupus erythematosus have pathogenic potential

✍ Jie Zhang; Annett M. Jacobi; Tao Wang; RoseAnn Berlin; Bruce T. Volpe; Betty Dia 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 624 KB